Gaush Meditech Ltd (HKG:2407)

Gaush Meditech Statistics

Total Valuation

Gaush Meditech has a market cap or net worth of HKD 1.35 billion. The enterprise value is 1.45 billion.

Market Cap	1.35B
Enterprise Value	1.45B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	Jun 23, 2025

Share Statistics

Gaush Meditech has 145.33 million shares outstanding. The number of shares has decreased by -0.77% in one year.

Current Share Class	145.33M
Shares Outstanding	145.33M
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-1.13%
Owned by Insiders (%)	44.51%
Owned by Institutions (%)	0.97%
Float	50.06M

Valuation Ratios

The trailing PE ratio is 12.19.

PE Ratio	12.19
Forward PE	n/a
PS Ratio	0.85
PB Ratio	0.73
P/TBV Ratio	3.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	13.02
EV / Sales	0.92
EV / EBITDA	5.99
EV / EBIT	8.08
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.40, with a Debt / Equity ratio of 0.28.

Current Ratio	2.40
Quick Ratio	1.28
Debt / Equity	0.28
Debt / EBITDA	2.12
Debt / FCF	n/a
Interest Coverage	6.16

Financial Efficiency

Return on equity (ROE) is 6.03% and return on invested capital (ROIC) is 4.75%.

Return on Equity (ROE)	6.03%
Return on Assets (ROA)	3.81%
Return on Invested Capital (ROIC)	4.75%
Return on Capital Employed (ROCE)	7.68%
Revenue Per Employee	1.93M
Profits Per Employee	136,329
Employee Count	884
Asset Turnover	0.54
Inventory Turnover	2.11

Taxes

In the past 12 months, Gaush Meditech has paid 73.15 million in taxes.

Income Tax	73.15M
Effective Tax Rate	40.65%

Stock Price Statistics

The stock price has decreased by -4.83% in the last 52 weeks. The beta is -0.09, so Gaush Meditech's price volatility has been lower than the market average.

Beta (5Y)	-0.09
52-Week Price Change	-4.83%
50-Day Moving Average	7.57
200-Day Moving Average	7.51
Relative Strength Index (RSI)	74.75
Average Volume (20 Days)	224,290

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Gaush Meditech had revenue of HKD 1.58 billion and earned 111.65 million in profits. Earnings per share was 0.76.

Revenue	1.58B
Gross Profit	735.57M
Operating Income	179.94M
Pretax Income	179.98M
Net Income	111.65M
EBITDA	242.64M
EBIT	179.94M
Earnings Per Share (EPS)	0.76

Balance Sheet

The company has 420.42 million in cash and 513.98 million in debt, giving a net cash position of -93.56 million or -0.64 per share.

Cash & Cash Equivalents	420.42M
Total Debt	513.98M
Net Cash	-93.56M
Net Cash Per Share	-0.64
Equity (Book Value)	1.84B
Book Value Per Share	12.54
Working Capital	667.38M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 46.63%, with operating and profit margins of 11.41% and 7.08%.

Gross Margin	46.63%
Operating Margin	11.41%
Pretax Margin	11.41%
Profit Margin	7.08%
EBITDA Margin	15.38%
EBIT Margin	11.41%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.30, which amounts to a dividend yield of 3.39%.

Dividend Per Share	0.30
Dividend Yield	3.39%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.77%
Shareholder Yield	4.28%
Earnings Yield	8.29%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	6